Deferasirox is an active pharmaceutical ingredient used in the manufacturing of medications for iron chelation therapy. It is a tridentate iron(III)-selective chelator with a triazole backbone, characterized by its aromatic rings and carboxylic acid group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 201530-41-8
Deferasirox Methyl Ester
pharmaceutical intermediate
Choline salicylate
pharmaceutical raw material
Amiloride hydrochloride
pharmaceutical raw material
Sivelestat sodium tetrahydrate
pharmaceutical raw material
Taltirelin hydrate
pharmaceutical raw material
4-[(3E,5E)-3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl](²H₄)benzoic acid
research compound
4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
BOFQWVMAQOTZIW-UHFFFAOYSA-N
C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O